Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.5, ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value ...

Despite its strong performance, HealthEquity faces several challenges ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

HealthEquity (HQY) stock dropped over 13% aftermarket trading ... Healthequity’s strong fundamentals and earnings performance, coupled with the pro-HSA political landscape, bolster her outlook.

HealthEquity (NASDAQ ... no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results.

HealthEquity, Inc. (NASDAQ:HQY) stock had a great 2024 ... Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether ...

In the fiscal fourth quarter of 2025, HealthEquity demonstrated strong performance with a 19% year-over-year revenue ... recently revised their earnings estimates downward, while the stock has ...

Revenue Growth: HealthEquity's remarkable performance in 3M is evident ... Typically, analysts will rate each stock once a quarter. Beyond their standard evaluations, some analysts contribute ...

For the quarter ended January 2025, HealthEquity (HQY) reported revenue of $311.82 million, up 18.8% over the same period last year. EPS came in at $0.69, compared to $0.63 in the year-ago quarter.